Form 8-K · Current report
Kroger 8-K, filed Oct 20, 2026
- Filed
- CIK
- 0000056873
- Accession no.
- 0001104659-26-117103
Summary
Kroger introduced a multi-year plan and new long-term financial targets at its October 20, 2026 investor update, including approximately 3% comparable sales growth in 2029 excluding fuel and pharmacy, 3%-6% adjusted EBITDA CAGR and 7%-11% adjusted net EPS CAGR for FY2027 through FY2029, excluding the pending Giant Eagle acquisition. The company reaffirmed its full-year 2026 guidance, and the new adjusted EPS target replaces its previous 8%-11% total shareholder return target, which had included dividend yield.
Key points
- Kroger's plan centers on three pillars: winning with the customer, driving profitable digital growth, and modernizing operations.
- CEO Greg Foran said Kroger is making value more visible and focusing resources closer to the customer.
- CFO David Kennerley said the framework reflects a renewed focus on the core grocery business and targets higher sales by 2029 with stronger adjusted EBITDA and adjusted EPS growth.
- Kroger said its capital allocation strategy remains focused on high-return growth investments, financial strength, and returning surplus capital through dividends and buybacks.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 7.01 Regulation FD. On October 20, 2026, The Kroger Co. (NYSE:KR) issued a press release in connection with its investor conference to be held on October 20, 2026. Attached hereto as Exhibit 99.1, and furnished herewith, is a copy of that release. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated October 20, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.